Skip to content

Effect of Dental Scaling on Male Infertility

Investigation of the Effect of Dental Scaling on Male Infertility in Patients Referring to the Infertility Center of Birjand

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250902067087N1
Enrollment
64
Registered
2025-09-22
Start date
2025-09-23
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infertility. Male infertility

Interventions

Intervention 1: Intervention group: In this study, the intervention consists of complete dental and periodontal scaling. Dental scaling is a non-invasive procedure using ultrasonic and manual instrume

Sponsors

Birjand University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: All men diagnosed with infertility or sperm analysis disorders People with gingivitis or mild to moderate periodontitis Willingness to participate in the study and provision of written informed consent Men with a minimum age of 20 and a maximum age of 50

Exclusion criteria

Exclusion criteria: Known genetic causes of infertility (e.g., genetic azoospermia) Presence of significant systemic diseases (e.g., diabetes, hormonal disorders) that may affect fertility History of testicular abnormalities (e.g., testicular atrophy, cryptorchidism, hypogonadism) History of testicular trauma or surgery Chronic prostatitis Varicocele Major viral infections (e.g., hepatitis) Previous infertility interventions or related surgeries (e.g., IVF or other assisted reproductive techniques)

Design outcomes

Primary

MeasureTime frame
Semen volume: Total ejaculate volume (mL). Sample collected by masturbation into a sterile plastic container after 3–5 days of sexual abstinence. Timepoint: Pre-intervention and 3 months post-intervention. Method of measurement: Measured in mL using a graduated pipette or calibrated cylinder after complete liquefaction, following WHO guidelines. Analysis performed within 30 minutes of collection.;Sperm concentration: Number of spermatozoa per milliliter of ejaculate (million sperm/mL). Timepoint: Pre-intervention and 3 months post-intervention. Method of measurement: Determined using a Neubauer hemocytometer (manual count) or Computer-Assisted Semen Analysis (CASA) if available, according to WHO guidelines. Sample collected after 3–5 days abstinence and analyzed within 30 minutes. Reported as million sperm/mL.;Sperm motility: Percentage of motile sperm in the sample (total motility = progressive + non-progressive). Progressive motility may be reported separately if required. Timepoint: Pre-intervention and 3 months post-intervention. Method of measurement: Assessed by light microscopy (typically ×400) according to WHO criteria; percentage of motile sperm recorded. If CASA is used, motility subcategories (progressive, non-progressive, immotile) will be reported. Analysis within 30 minutes of collection.;Sperm morphology: Percentage of sperm with normal morphology according to the WHO morphology criteria. Timepoint: Pre-intervention and 3 months post-intervention. Method of measurement: Slides prepared and stained and morphology assessed under microscopy according to WHO criteria. Results reported as percentage normal forms. Assessment performed by trained personnel.

Secondary

MeasureTime frame
Periodontal status: Gingivitis, Mild Periodontitis, Moderate Periodontitis, Healthy. Timepoint: Pre-intervention and 3 months post-intervention. Method of measurement: Periodontal assessment includes Plaque Index (PI), Gingival Index (GI), Probing Depth (PD), Clinical Attachment Loss (CAL), and Bleeding on Probing (BOP). Indices are recorded according to Silness and Löe criteria. PD measured at six sites per tooth; CAL reported in millimeters. Periodontal status classified as Gingivitis (=2 sites with GI>0, no CAL) or Periodontitis (presence of CAL), further categorized by severity: Mild (1–2 mm CAL), Moderate (3–4 mm CAL), or Healthy.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaede Nayerabadi

Birjand University of Medical Sciences

Marinaierabadi76@gmail.com+98 56 3239 5000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026